- 건국대학교

	Konkuk Strengthens Research Capacity through University-Industry Cooperation
	관리자		909		2015.03.11

Konkuk University's (KU) university-industry cooperation model is an advanced type which utilizes both research capacity and commercialization, through the University's vast network with corporations and domestic and international research institutes established upon its superb research capacity. The secret to the University's dynamic progress in the past decade is not only the production of new knowledge but also its dissemination through its cooperation with the industry.
To maximize research outcomes and vitalize university-industry cooperation, KU has been strengthening researcher-centered programs. Consequently, the amount of extramural research grants increased dramatically to about 91 million USD in 2013, while revenue from technology transfer recorded approximately 0.87 million USD. For five years since 2009, KU has submitted up to 1,579 patent applications and was placed 4th in the number of intellectual property rights (IPRs), enhancing Konkuk's reputation as an institution with outstanding research performance.
In addition to traditionally strong academic disciplines such as bioscience and biotechnology, agriculture and animal science, veterinary science, and biomedical science, Konkuk is broadening its scope of university-industry cooperation through aerospace engineering, cutting-edge memory elements, and convergence technology of new materials.
A representative example of Konkuk's university-industry cooperation is the promotion of the establishment of an animal vaccine R&D center based on the technology developed by KU College of Veterinary Medicine. The patented technology of"K2 Vaccine," a preventive vaccine for avian infectious bronchitis, has been continually developed and commercialized by Prof. Chang Seon Song of Dept. of Veterinary Medicine, which has led to technology transfer and increased revenues.
A KU personnel commented, "Konkuk ranks 2nd place in the world for the number of publications per faculty in biomedical science research. Based on such capacity, we plan to establish and develop an animal vaccine R&D center as a subsidiary company of Konkuk Technology Holdings to make it one of the top 10 research centers in the field."
As Konkuk conducts full-scale commercialization through university-industry cooperation, corporations are showing growing interest in investing in Konkuk's research endeavors. An example is the investment of domestic bioventure firms in the development of anticancer substances carried out by Prof. Yoongho Lim, Young Han Lee, and Soonyoung Shin of KU College of Bioscience & Biotechnology.
* This article is an edited and translated version of the original article published by the Dong-A Ilbo (Oct. 29, 2014)
 
Source: KU Newsletter (March 2015 Issue)
Link: <a href="../../Administration/Abroad/newsletter/march2015/research01.jsp" target="_blank">http://www.konkuk.ac.kr/Administration/Abroad/newsletter/march2015/research01.jsp</a>
<img src="ArticleFile.do?id=11618803" />
Posted by Eun Jin Cho

	research.jpg (50,069)
	Award Ceremony for ‘2014 KU R...
	KU and Johns Hopkins Universi...